Dermoscopy + Triple Light Source Reliable in ID of Pityriasis Rosea

Share this content:
Dermoscopy + Triple Light Source Reliable in ID of Pityriasis Rosea
Dermoscopy + Triple Light Source Reliable in ID of Pityriasis Rosea

WEDNESDAY, Feb. 15, 2017 (HealthDay News) -- Dermoscopy with three light sources is ideal for diagnosing pityriasis rosea (PR), according to a research letter published online Feb. 10 in the International Journal of Dermatology.

Mary Thomas, D.N.B., from the King Edward Memorial Hospital in Mumbai, India, and colleagues examined the role of dermoscopy with a triple light source in the diagnosis of PR. Ten consecutive biopsy-proven cases of PR that presented to the hospital underwent clinical and dermoscopic evaluation. The dermoscope used was a triple light source, with non-polarized light (NPL), polarizing light (PL), and ultraviolet light (UVL).

The authors note that eight of the patients had classical PR and two had papular PR. No background abnormalities in pigmentation or vascularity were noted on dermoscopic evaluation using NPL. The typical collarette of scaling was identified in six patients, although all patients had scaling. Under PL, five of eight patients with classical lesions had patchy globular dilatation of the dermal vasculature. Punctate dilatation of vessels within the lesion was seen for one of two patients with papular PR. When examined with UVL, the hanging curtain was clearly demonstrated in all cases, but none of the other features were appreciable.

"Based on the findings of our pilot study, we suggest videodermoscopy with a triple light source as a quick, noninvasive, and reliable diagnostic tool for PR," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »